GL0034

· Sun Pharmaceutical Industries Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GL0034, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus [Phase 2]